Cardiovascular Systems Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
136,612.00
178,813.00
176,911.00
204,906.00
217,043.00
Cost of Goods Sold (COGS) incl. D&A
31,165.00
39,520.00
35,421.00
39,441.00
39,484.00
Gross Income
105,447.00
139,293.00
141,490.00
165,465.00
177,559.00
SG&A Expense
138,936.00
171,930.00
187,203.00
167,007.00
175,325.00
EBIT
33,489.00
32,637.00
45,713.00
1,542.00
2,234.00
Unusual Expense
716.00
-
10,364.00
-
-
Non Operating Income/Expense
51.00
162.00
53.00
47.00
34.00
Interest Expense
1,034.00
23.00
-
500.00
1,717.00
Pretax Income
35,290.00
32,822.00
56,024.00
1,706.00
1,844.00
Income Tax
-
-
-
86.00
132.00
Consolidated Net Income
35,290.00
32,822.00
56,024.00
1,792.00
1,693.00
Net Income
35,290.00
32,822.00
56,024.00
1,792.00
1,693.00
Net Income After Extraordinaries
35,290.00
32,822.00
56,024.00
1,792.00
1,693.00
Net Income Available to Common
35,290.00
32,822.00
56,024.00
1,792.00
1,693.00
EPS (Basic)
1.25
1.04
1.72
0.06
0.05
Basic Shares Outstanding
28,295.80
31,547.70
32,537.60
32,373.70
33,145.10
EPS (Diluted)
1.25
1.04
1.72
0.06
0.05
Diluted Shares Outstanding
28,295.80
31,547.70
32,537.60
32,373.70
33,614.30
EBITDA
32,122.00
30,316.00
41,796.00
2,593.00
6,168.00
Non-Operating Interest Income
-
-
-
383.00
1,293.00
Other After Tax Income (Expense)
-
-
-
-
19.00
About Cardiovascular Systems
View Profile
